Cue Biopharma Inc (CUE)
1.705
+0.22
(+14.81%)
USD |
NASDAQ |
Nov 05, 16:00
1.74
+0.04
(+2.05%)
After-Hours: 18:59
Cue Biopharma Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 74.73% |
| Arbutus Biopharma Corp | -- |
| GlycoMimetics Inc | -- |
| FibroGen Inc | 89.78% |
| Cidara Therapeutics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -132.3% |
| Return on Assets | -78.30% |
| Return on Invested Capital | -107.6% |
| Profit Margin (Quarterly) | -382.7% |
| Operating Margin (Quarterly) | -390.6% |
| Return on Net Operating Assets | -536.4% |